Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Cardiac surgery Stories

2014-04-17 16:27:22

MEMPHIS, Tenn., April 17, 2014 /PRNewswire-USNewswire/ -- More than 20 percent of Le Bonheur Children's Hospital's open heart surgeries are now bloodless, meaning no blood or blood products given during surgery. The Memphis, Tenn., hospital's Heart Institute has been taking aggressive steps to minimize blood loss during surgery and reduce perioperative blood transfusions over the last 18 months. http://photos.prnewswire.com/prnvar/20140417/76284 "Blood transfusions increase a...

2014-04-16 08:32:01

Funding Will Enable Initiation of Blinded, Randomized Clinical Trial and Expanded Commercialization of CARILLON® Mitral Contour System® KIRKLAND, Wash., April 16, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced the completion of a $20 million financing. M. H. Carnegie & Co. and Lumira Capital led the financing as part of an international syndicate of institutional investors from Australia, the U.S. and Canada. The financing follows the company's completion...

2014-04-15 14:43:23

Doctors at Henry Ford Hospital reached a medical milestone April 3, performing the 25th successful transcatheter valve replacement using a novel way to access the heart. Henry Ford is the only hospital in the United States performing the unique procedure called transcaval valve replacement, which accesses the heart by temporarily connecting major blood vessels. Northern Michigan resident Viola Waller, 80, underwent Henry Ford’s first transcaval procedure on July 3, 2013 when...

2014-04-15 08:30:17

DUBLIN, Apr. 15, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/7pz39r/global_heart) has announced the addition of the "Global Heart Valves and Transcatheter Valves Market Report" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The analysts forecast the Global Heart Valve and Transcatheter Heart Valve market to grow at a CAGR of 11.44 percent over the period 2012-2016. One of the key factors contributing to this market...

2014-04-14 23:00:39

A team of Washington University cardiologists and cardiothoracic surgeons recently were first in the region, outside clinical trials, to use the new CoreValve System when performing transcatheter aortic valve replacement (TAVR) procedures. The two patients who received the self-expandable valve, both considered to be at extreme-risk for traditional aortic valve replacement, are recovering at home. St. Louis, MO (PRWEB) April 14, 2014 Specialists at the Washington University and...

2014-04-11 23:24:34

Valves in the Heart of the Big Apple is the premiere international scientific conference providing state-of-the art information on the diagnosis, evaluation, intervention, surgical management and treatment of heart valve disease. Through state-of-the-art lectures, Meet the Expert and teaching sessions, hands-on classes and more, it will get to the core of this emerging public health issue. New York, NY (PRWEB) April 11, 2014 The Sixth Annual Joint Scientific Session of the Heart Valve...

2014-04-09 16:26:11

ROSEVILLE, Minn., April 9, 2014 /PRNewswire/ -- Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company developing technologies for transcatheter mitral valve replacement, announced today that it has secured $25 million in an oversubscribed Series C financing led by Apple Tree Partners, along with Boulle Group members and other existing investors. Proceeds will be used for validation of Tendyne's novel Transcatheter Mitral Valve Implant to treat...

2014-04-02 08:34:41

At One Year, Patients Showed Significantly Lower Fatality and Improved Quality of Life HARRISBURG, Pa., April 2, 2014 /PRNewswire-iReach/ -- Results from a groundbreaking study performed at PinnacleHealth were revealed this weekend at the American College of Cardiology's 2014 Scientific Sessions and simultaneously published in The New England Journal of Medicine. (Photo: http://photos.prnewswire.com/prnh/20140402/MN95343) "In patients with aortic valve stenosis, the self-expanding...

2014-04-02 00:23:28

These and Other Studies Reinforce Global Commitment to the Development of Innovative Therapies to Improve Care for Patients with Cardiovascular Disease NATICK, Mass., April 1, 2014 /PRNewswire/ -- Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation (NYSE: BSX) reported favorable results in studies related to cardiac resynchronization therapy (CRT), platinum chromium stent platforms and...

2014-03-31 13:26:39

Among patients undergoing aortic valve replacement using a catheter tube, a comparison of two types of heart valve technologies, balloon-expandable or self-expandable valve systems, found a greater rate of device success with the balloon-expandable valve, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. Transcatheter aortic valve replacement (TAVR) has emerged as a new option for patients with severe...


Latest Cardiac surgery Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »